Cellular immune response to hepatitis-C-virus in subjects without viremia or seroconversion: is it important?

Hepatitis C Virus (HCV) causes chronic infection and represents a global health burden. To date, there is no licensed vaccine for HCV. The high viral replication rate and the existence of several HCV genotypes and quasispecies hamper the development of an effective universal vaccine. In this regard,...

Descripción completa

Detalles Bibliográficos
Autor principal: Abdelwahab, Sayed F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867533/
https://www.ncbi.nlm.nih.gov/pubmed/27186234
http://dx.doi.org/10.1186/s13027-016-0070-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867533/
https://www.ncbi.nlm.nih.gov/pubmed/27186234
http://dx.doi.org/10.1186/s13027-016-0070-0

Ejemplares similares